Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2006 026 388.0 |
96 | EP file number | EAKZ | 06 75 4599.6 |
86 | WO file number | WAKZ | PCT/EP2006/006220 |
97 | EP publication number | EPN | 1896063 |
87 | WO publication number | WPN | 2007000327 |
54 | Designation/title | TI | IMMUNOGENE ZUSAMMENSETZUNG |
51 | IPC main class | ICM (ICMV) | A61K 39/095 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/102 (2006.01), A61K 39/116 (2006.01) |
22 | DE application date | DAT | Jun 23, 2006 |
96 | EP application date | EAT | Jun 23, 2006 |
86 | WO application date | WAT | Jun 23, 2006 |
43 | Date of first publication | OT | Jan 4, 2007 |
| Date of publication of grant | PET | Dec 14, 2011 |
71/73 | Applicant/owner | INH | GlaxoSmithKline Biologicals S.A., Rixensart, Brussels, BE |
72 | Inventor | IN | DENOEL, Philippe,GlaxoSmithKline Biologicals s.a., B-1330 Rixensart, BE; POOLMAN, Jan,GlaxoSmithKline Biologicals s.a., B-1330 Rixensart, BE; BOUTRIAU, Dominique,GlaxoSmithKline Bio. s.a., B-1330 Rixensart, BE; CAPIAU, Carine,GlaxoSmithKline Biologicals s.a., B-1330 Rixensart, BE; DUVIVIER, Pierre,GlaxoSmithKline Biologicals s.a., B-1330 Rixensart, BE; BIEMANS, Ralph L.,GlaxoSmithKline Biologicals s.a, B-1330 Rixensart, BE |
74 | Representative | VTR | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0513069 Jun 27, 2005
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0513071 Jun 27, 2005
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0524204 Nov 28, 2005
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0526040 Dec 21, 2005
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0515556 Jul 28, 2005
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 0526041 Dec 21, 2005
|
| Due date | FT FG | Jun 30, 2025 Annual fee for the 20th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | HR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001896063 Searchable text:
EP000001896063 Original document:
EP000001896063B1 Searchable text:
EP000001896063B1 Original document:
WO002007000327 Searchable text:
WO002007000327 |
43 | Date of first publication | EVT | Jan 4, 2007 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 12, 2024 (Show all update days)(Hide all update days)- Nov 12, 2024
- May 28, 2024; Jun 3, 2023; May 26, 2022; Apr 30, 2022; Jun 1, 2021; Nov 30, 2020; May 25, 2020; Aug 17, 2019; May 24, 2019; Feb 21, 2019; Oct 30, 2018; Jun 20, 2018; Apr 12, 2018; Jul 12, 2017; Jul 8, 2017; Jul 14, 2016; Apr 7, 2016; Mar 3, 2016; Jul 17, 2015; Jul 8, 2015; Jul 23, 2014; Jul 8, 2014; Jul 25, 2013; Jul 9, 2013; Feb 1, 2013; Dec 6, 2012; Jul 19, 2012; Jul 10, 2012; Mar 24, 2012; Mar 1, 2012; Feb 16, 2012; Dec 24, 2011; Dec 15, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|